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Abstract 
Although contemporary stents have been shown to improve short and long term clinical 
outcomes, the optimum dilation protocol is still uncertain in challenging cases characterised by 
long, highly calcified and tortuous anatomy. Recent clinical studies have revealed that in these 
cases, sub-optimal delivery can result in stent thrombosis (ST) and/or neointimal thickening as a 
result of stent malapposition (SM) and/or severe vessel trauma. One of the major contributors to 
vessel trauma is the damage caused by balloon dilation during stent deployment. In the present 
work, a Kriging based response surface modelling approach has been implemented to search for 
optimum stent deployment strategies in a clinically challenging, patient specific diseased 
coronary artery. In particular, the aims of this study were:  i) to understand the impact of the 
balloon pressure and unpressurised diameter on stent malapposition, drug distribution and wall 
stresses via computer simulations and ii) obtain potentially optimal dilation protocols to 
simultaneously minimise stent malapposition and tissue wall stresses and maximise drug 
diffusion in the tissue. The results indicate that SM is inversely proportional to tissue stresses and 
drug deliverability. After analytical multi-objective optimisation, a set of “non-dominated” 
dilation scenarios was proposed as a post-optimisation methodology for protocol selection. Using 
this method, it has been shown that, for a given patient specific model, optimal stent expansion 
can be predicted. Such a framework could potentially be used by interventional cardiologists to 
minimise stent malapposition and tissue stresses whilst maximising drug deliverability in any 
patient-specific case.  
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1. Introduction 
Clinical studies have revealed that contemporary devices, especially DES, demonstrate better 
short and long term outcomes than bare metal stents (BMS) (Stefanini and Holmes, 2013) and 
the second and third generation DES are critically superior to first generation DES. However, 
clinical complications have been reported which are associated with the recent advances in stent 
design, the implantation protocol and the complexity of the treated vessel (Cook et al., 2007; 
Hanratty and Walsh, 2011; Hong et al., 2006; van der Hoeven et al., 2008; Williams et al., 2012).  
One of the adverse outcomes in such anatomies is stent malapposition (SM) in which the stent is 
insufficiently expanded resulting in further unwanted events such as delayed neointimal healing, 
incomplete endothelialisation and higher levels of both neointimal proliferation and thrombus 
deposition, which give rise to clinical sequence in the form of restenosis and ST, respectively 
(Cook et al., 2007; Ozaki et al., 2010). 
SM is largely dependent on multiple factors including the “reference diameter”1 and the balloon 
inflation pressure (Cook et al., 2007; van der Hoeven et al., 2008). Depending on the vessel 
length and its anatomy, reference diameter is normally calculated in the distal end of the target 
lesion. This often results in malapposed struts in the proximal end of the stented segment 
particularly in a longer lesion, which has a diameter discrepancy between the proximal and distal 
end. When SM is detected, a non-compliant balloon is inflated in the malapposed region to 
reshape the stent and increase the stent area. However, such post-stenting procedures may trigger 
further clinical complications including vessel wall dissection or stent fracture (Hanratty and 
Walsh, 2011). Therefore, it is preferable to limit stenting to a single step approach resulting in i) 
                                                 
1
 Reference diameter is defined as the diameter of a healthy arterial cross section along the length of the intervened 
segment. Interventional cardiologists size the stent which is to be implanted according to the non-diseased diameter 
in the distal part of the segment. 
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maximum stent strut apposition, ii) minimum vessel stress and iii) maximum drug diffusion to 
the vessel walls. 
In this study, the optimal dilation strategy in a patient-specific right coronary artery (RCA) has 
been investigated by finite element analysis (FEA) and surrogate modelling. Firstly, twenty 
different dilation protocols were parameterised with respect to the balloon unpressurised 
diameter and the balloon pressure. For each dilation protocol FEA simulations were performed 
for the deployment of a representative Xience stent model (Abbott Laboratories, IL, USA) into 
the reconstructed RCA. Performance was measured by three figures of merit (objective 
functions) representing i) tissue stresses, ii) stent malapposition and iii) drug delivery. Surrogate 
models were constructed for each objective function to describe the functional relationship 
between the input parameters and the performance. Then, based on a dedicated population based 
algorithm, non-dominated designs (optimum dilation scenarios) were obtained. Three update 
points were taken along the Pareto front and further computer simulations were carried out to 
improve the surrogates. This process was repeated until a stopping criterion was met. 
2. Materials and methods 
2.1. Geometry & mesh discretisation 
2.1.1. Artery, plaque, dilation catheter, stent platform  
Detailed information on the artery reconstruction process, the stent and balloon models, material 
properties, mesh discretisation and the stability of the numerical simulations can be found in 
previous work (Ragkousis et al., 2015; Ragkousis et al., 2014). 
2.1.2. Dilation strategy parameterisation 
The balloon profile and the inflation pressure were taken as the design variables of this 
optimisation problem. All the balloons were six-folded. However, depending on the 
parameterised balloon-profile length (unpressurised diameter), the folding configuration was 
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varied to fit in the semi-crimped stent. The design space was defined by: i) the initial diameter 
sampled around ± 20% of the baseline model and ii) the inflation pressure varying between 0.6-
1.5 MPa, a range widely used in stenting practice. 
2.2. Simulations 
2.2.1. Stent expansion 
The expansion simulations were carried out in the commercially available FEA solver, 
Abaqus/Explicit v.6-12 (Simulia Corporation, USA). The events were simulated as quasi-static, 
therefore, the time period of the simulations were defined by running frequency analysis in 
ABAQUS/Standard to extract the first fundamental frequency of the stent structure (Ragkousis et 
al., 2014). For the baseline model, the parameters were chosen according to the reference 
diameter measured in the distal part of the reconstructed segment. Then, a virtual balloon was 
generated and calibrated according to a compliance chart given by the manufacturer (De Beule et 
al., 2008; Ragkousis et al., 2015). 
2.2.2. Drug release 
After stent deployment, the deformed artery and stent geometry was used to simulate drug 
release in the walls of the vessel.  A heat transfer solution scheme was used as an analogue of the 
drug delivery process similarly to the work presented by Hose et al. (2004). The release of the 
drug was simulated as a steady state event by using the forced heat convection analysis 
capability of ABAQUS/Standard. The boundary conditions for the transport simulation were 
defined as in other studies (Feenstra and Taylor, 2009; Hose et al., 2004; Pant et al., 2012; 
Zunino, 2004). 
2.3. Objective functions 
Three objective functions were considered in this study. Two objectives were extracted after the 
stent expansion and one after the drug release simulation (see Appendix A). 
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2.3.1. Volume average stress (VAS) 
The VAS metric represents the induced mechanical environment after the stent expansion. It is 
an index indicating the average stress change within a fixed volume (intima-media wall). VAS 
has been presented by Holzapfel et al. (2005b) and successfully implemented in recent studies 
(Pant et al., 2012; Pant et al., 2011; Ragkousis et al., 2015). 
2.3.2. Area average stent malapposition (AASM) 
Ragkousis et al. (2015) proposed AASM to calculate the average stent malapposition after stent 
expansion in reconstructed arterial segments. This index expresses the area of malapposed struts 
within the fixed outer area of the stent surface. 
2.3.3. Volume average drug (VAD) 
Similarly to the VAS index, a volume average index for drug release was proposed by Pant et al. 
(2012) to measure the amount of drug transported into the tissue. VAD expresses the average 
drug diffusion within a fixed volume (intima-media wall). 
2.4. Optimization problem & solution methodology 
The multi-objective optimisation problem considered in this study was formulated as: 
                  (1.1) 
                   (1.2) 
                   (1.3) 
such that 
               (1.4) 
           (1.5) 
where         are the diameter and the pressure parameters, respectively. Note that VAD index 
should be maximised. However, the negative sign was included so that lower values of -VAD 
indicate better performance. Therefore, the aim was to minimise –VAD.   
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In Fig. 1, a flow chart detailing the optimisation process followed in this study is depicted. The 
process commenced with an optimal distribution of the initial sampling points in the design 
space, followed by structural and drug simulations for each design configuration. Discrete values 
of the performance metrics were extracted to construct Kriging response surface models for each 
metric. The models were then searched by a population-based algorithm to obtain optimum 
solutions for surrogate model improvement. From the optimum set, three points were selected as 
infill points to the initial sampling plan or the previous optimisation step. The process stopped 
when the stopping criterion was met (see section 2.4.2).      
2.4.1. Sampling plan 
The initial two-dimensional design space consisted of twenty points optimally distributed as a 
function of balloon unpressurised diameter and balloon pressure. This sampling plan, or Design 
of Experiment (DoE), was constructed by an optimized Latin-hypercube (LHC) (Morris and 
Mitchell, 1995). 
2.4.2. Surrogate modelling, NSGA-II & infill strategy 
The pyKriging package (http://www.pykriging.com/) (Paulson and Ragkousis, 2015) was used to 
construct the surrogates and guide the multi-objective optimization study. A validation of the 
algorithms that were used in this study is presented in Supplementary material S1. A non-sorting 
genetic algorithm (NSGA-II) (Deb, 2001), as implemented in pyOpt (http://www.pyopt.org) 
(Perez et al., 2012) was used to extract the optimal Pareto Front after each optimisation phase.  
Surrogate models 
To model the response of each objective function to variations in balloon pressure and 
unpressurised diameter a Gaussian Process (GP) methodology, known as Kriging, was used. 
Appendix B contains the basic equations for Kriging model construction. For detailed derivation, 
consult the work by Jones (2001) and Forrester et al. (2008). Kriging models have been also 
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implemented successfully in previous studies on stent optimisation, such as in Pant et al. (2011) 
and Gundert et al. (2012). For a detailed overview in recent optimisation and surrogate modelling 
studies, consult the review paper by Bressloff et al., 2015, including reference to early studies 
such as the one by Timmins et al 2007. 
Validation of surrogates 
Once the surrogates were built, validation was performed using the standardised cross validated 
residual (Jones et al. 1998), expressed as  
       
 (    )   ̂  ( 
   )
√     
          
  
(2) 
where   is the observed value at the i-th point (point that is left out),  ̂   denotes the prediction of 
the i-th leave out point and     is the posterior variance of the prediction at the left out point. 
Validity of each model was tested against the target to have each point within plus or minus three 
standard errors (99.7% confidence). Further, a “leave-one-out” method was used to test for 
model reliability (Jones et al., 1998). Again, for each surrogate model, one point of the DoE was 
left out and a surrogate model with constant parameters constructed for the remaining sampling 
points. Then, a prediction was made at the point that was left out and compared to the actual 
value. This process was repeated for all the points that comprise the DoE and a correlation 
residual was calculated for each model.  
NSGA-II  
The superiority of Gaussian models is the fact that such surrogates contain the estimation of 
model uncertainty, expressed by the mean square error (MSE). This is very useful for the so-
called “exploration” of the design space by adding infill points in regions where the uncertainty 
is the maximum. Additionally, a highly attractive tool in stochastic optimisation is the expected 
improvement (EI) (Jones et al., 1998), which indicates the magnitude of improvement towards 
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the optimum solution. Both the MSE and the EI are defined in Appendix B. Since the EI can be 
evaluated for each objective function, NSGA-II was used to search the Pareto Front for 
maximisation of the multi-objective EI. 
Infill strategy and convergence criterion 
In each optimisation phase, two steps were performed to select update points. In the first step, 
three points were selected with two of the points positioned at the ends and a third point located 
in the middle of the Pareto Front. The second step comprised the mapping of these points to the 
design space to check their shortest distance with respect to the initial/previous sampled points. 
Around each update point, a circle with radius equal to 1% of the variable range (0.01 here since 
the variables were normalised in the range [0-1]
2
) was constructed and if there was no point 
already sampled in this circle, the selection was approved. Otherwise, the point was rejected and 
the next Pareto point was selected. The first step ensures exploitation while the second step 
contributes to the exploration (very essential in a mathematical optimisation routine). In this 
study, due to the high computational cost for each simulation (average point simulation duration 
was approximately 160 hours on a 32GB RAM node, split over 32 domains), a convergence 
criterion was set to avoid a large number of optimisation iterations. In particular, in each step, 
updated surrogates were constructed containing the infill points from the previous iteration and a 
second NSGA-II search (this time on the updated response surfaces of the prediction) were 
carried out. Then, an optimum point was calculated as the Pareto Front point with the minimum 
Euclidean distance from the ideal vector/“utopia” point. More specifically, the obtained Pareto 
Front was normalised with respect to the utopia (ideal vector) and the nadir (maximum objective 
function vector) point as 
  ̅     
        
 
  
     
  
(3) 
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where      ,   
   and   
 , the non-normalised objective function value, the minimum objective 
function value and the maximum objective function value of the i
th
 model, respectively 
(Miettinen, 1998). Then, the minimum Euclidean distance was expressed by the weighted 
          proposed by Miettinen (1998) as  
minimise        (∑   |         
 |     )
   
 (4.1) 
subject to     , (4.2) 
with   being the entire search space and ∑     
 
   . When the predicted optimum point 
(with         = 1/3) was the same in two subsequent iterations, the optimisation process was 
terminated. 
3. Results and discussion 
3.1. Baseline and DoE point simulations and Kriging interpolation 
The results for the baseline model are reported in the first row of Table 1. From the second to the 
last row of Table 1, the discrete objective function evaluations of the initial DoE are reported. 
Surrogate models were constructed for each objective function. The response surfaces along with 
the MSE and the EI of the surrogates are depicted in Fig. 2. The x-axis and the y-axis represent 
the normalised balloon diameter and pressure, respectively. It can be noted that the diameter 
parameter has a stronger effect than the pressure for all models. In the first column of Fig. 2, the 
model predictions indicate that stent malapposition is inversely proportional to tissue stress and 
drug diffusion (note that drug diffusion contours or +VAD, would have the opposite behaviour 
from -VAD). Consequently, VAS is competing against both AASM and -VAD. This can be 
explained by the fact that when SM decreases, more stent struts interact with the vessel walls and 
higher tissue stresses are imposed by the stent, especially when using higher balloon pressures. 
Moreover, since more struts interact with the wall, the drug diffusion is increased. In contrast, 
when malapposition increases, the drug diffusion is decreased (-VAD is increased) as a result of 
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the reduced wall-stent interaction. In the second column of Fig. 2, MSE error indicates that high 
uncertainty exists in the corners for all the surrogates. This is expected as, in this optimisation 
study; LHC was used to generate the initial DoE leaving the corners and the edges of the design 
space un-sampled. Finally, in the third column, the EI indicates where model improvement can 
be obtained via infilling the design space in regions where EI is maximum. In general, the EI 
tends to be large in regions where the predicted value is larger than the minimum actual value 
(extracted by the simulations) and/or there is a high level of uncertainty associated with the 
prediction. 
3.2. Validation of the surrogates 
On the left column of Fig. 3, the        values for all the Kriging models are reported. It can be 
observed that all points lie within the interval         for all the surrogate models. The leave-
one-out plots are depicted in the right column of Fig. 3. As can be observed, all the surrogate 
models predict close function values to their corresponding “actual” values (extracted by the 
computational analyses). This is evident by the fact that the leave-one-out plot has approximately 
linear behaviour with in all cases (    was 0.97, 0.92 and 0.95 for VAS, AASM and VAD, 
respectively). 
3.3. Infill point simulations, update Kriging construction and selection criteria 
The nine infill point parameter values along with the objective function evaluations at each point 
are reported in Table 2. The corresponding updated surrogates in each optimisation iteration are 
depicted in Fig. 4. It can be noted that the maximum and minimum values of all the surrogates 
appear to be close to convergence from the second optimisation iteration. In Fig. 5, the EI of 
each model from the initial step (first row), to the last optimisation step (last row) are depicted. 
The implemented algorithm selects points on the Pareto Front where the EI is the maximum. 
Since two of the objectives (AASM and VAD) have relatively similar behaviour, the first update 
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is chosen based in an average of both maximum EI values. The second update is selected where 
the EI for VAS is the maximum and the third update is selected in the middle part of the Pareto 
front. As discussed in section 2.4.2, the optimisation process is stopped when the convergence 
criterion is met. In the last two optimisation steps the Pareto Front obtained by NSGA-II run 
using the prediction surfaces is not significantly changed. Consequently, the same optimum point 
is predicted. 
3.4. Visualisation of the simulated sampling points 
In Figs. 6 and 7, spatial SM and wall circumferential stress contours, respectively, are mapped to 
the deformed simulated models. It is evident that models with reduced SM result in higher tissue 
stresses (c.f. Tables 1 and 2), for instance DoE_08, DoE_11, DoE_12, DoE_16, DoE_18, 
UPD_12, and UPD_22. This is expected from the fact that luminal gain leads to higher stresses 
in the arterial wall. Especially in DoE_08, DoE_11, UPD_12 and UPD_22, the increased VAS 
index is as a result of stent over-expansion.  Interestingly, while DoE_11 and DoE_12 have 
similar strut apposition results, the VAS index for the DoE_11 is 12.66% higher. Such stress 
differences between models may lead to biomechanical responses which in turn may result in 
different restenosis rates in the dilated segment. This has been shown in recent studies (Keller et 
al., 2014; Timmins et al., 2011) reporting localised biological response as a result of mechanical 
forces imposed by the stent system during deployment and, consequently, the radial compression 
of the arterial wall. On the other hand, models with low induced mechanical environment are as a 
result of suboptimal stent and wall interaction or stent under-expansion. This is well 
demonstrated in models DoE_02, DoE_09, UPD_11 and UPD_21 where, especially for the 
proximal parts, severe stent malapposition is observed which, in clinical practice, would likely 
necessitate post-operational manoeuvrings to restore the malapposed struts. These findings 
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suggest that a dilation protocol should be used that balances lumen gain and the imposed 
mechanical stress environment for a given specific case.  
3.5. Post-optimisation point selection 
Generally, once a final Pareto Front is obtained, the weighted           can be implemented 
to locate optimum points according to a user’s preference. This post-optimisation technique, 
which is also known as “compromise programming”, picks a solution which is minimally located 
from a given reference point (Deb, 2001). Then, according to the user’s judgment and the given 
patient-specific case, corresponding weights to each objective function can be applied and, by 
minimising the weighted          , the optimum point can be located. In the current study, 
the reference point was the ideal vector (utopia point). The first point selected was the closest 
Pareto Front point to the ideal vector. To locate this point, equal weights were used in Eq. 4. In 
Fig. 8, the final Pareto Front obtained by a NSGA-II search of the prediction models is depicted. 
The Pareto Front is normalised according to the nadir and utopia point (c.f. Eq. 3). The minimum 
Euclidean distance or, alternatively, the weighted            is the same in the last two 
iterations. Consequently, the same optimum point is predicted. In Fig. 8a, the sphere represents 
equal weighted           (with         = 1/3), and its radius is tangent to the Pareto Front 
point which, in turn, is the closest point to the utopia point. In Fig. 8b, the elliptical sphere 
represents a non-equal weighted          . By way of example, the weights that were applied 
to the minimisation problem were                      . Its long axis is equal to the 
Euclidean distance between the ideal vector and the point for which the weighted            is 
the minimum. Its short axes are equal to the minimum weighted          . Therefore, with 
this method, a Pareto Front point can be easily located in which an objective function is made to 
have higher importance than the others. In Fig. 8b, AASM has been assigned a greater weight to 
locate a dilation protocol for which stent malapposition is of greater importance. 
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3.6. Model limitations 
The main limitations of this work are associated with the constitutive material models 
characterising i) the walls of the vessel and ii) the balloon models. The vessel walls were 
assumed to be hyper-elastic and isotropic, modelled by reduced polynomial strain energy 
functions (Gastaldi et al., 2010; Pant et al., 2011). In reality, the wall deformation is 
characterised by hyper-elastic anisotropic behavior and has been successfully modelled by more 
advanced constitute laws such as the model proposed by Holzapfel et al. (2005a). With respect to 
the balloon, inflation behavior was considered to be linear elastic and isotropic where, in reality, 
the balloon behaves as a non-linear cylindrically orthotropic membrane (Kiousis et al., 2009). 
However, the balloon models were calibrated according to actual compliance charts. Therefore, 
the virtual expansion behavior closely matches that which occurs in clinical practice, especially 
at nominal pressures. Due to the comparative nature of the current work along with the fact that 
there is no clinical record of the investigated performance indices, the implemented constitutive 
models can still provide valuable and reliable results. 
4. Conclusion 
The presented work investigated the optimisation of a dilation protocol in a patient-specific RCA 
using balloon pressure and unpressurised balloon diameter as variables. In particular, the 
mechanical performance of a modest number of protocol realisations was predicted for metrics 
that quantify tissue stress, stent strut malapposition and drug delivery. Due to the expense of 
FEA simulations for each realisation, a Kriging surrogate modelling approach was employed 
using updates selected from the multi-objective Pareto front derived from the expected 
improvement of each objective function. Then, a post-optimisation method was used to 
demonstrate how, for a given patient specific case, optimum interventional protocols can be 
derived, balancing the competing objectives of tissue stress and strut malapposition. The 
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proposed approach thus provides a tool for dilation system selection (e.g. alternative size 
balloons and compliance charts could be supplied for a given stent) and design optimization of 
lesion-specific dilation systems, a process that will become realizable in non-urgent cases with 
increases in computer power. 
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Figure 1. Flow chart on the description of the adopted optimisation methodology of this 
study 
 
Figure 2. Surrogate models interpolated to the objective function evaluations after the 
initial DoE. From up to bottom, surrogates for VAS, AASM, and VAD are depicted. From 
left to right, Kriging interpolation surface of the prediction, MSE and EI for each model.   
 
Figure 3. Surrogate model validation: On the left panel, SCVR values for all models 
(rows). On the right panel, leave-one-out plots for all models (rows).   
 
Figure 4. GP interpolation surfaces for the three models (columns) after each optimisation 
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iteration (rows).  
 
Figure 5. NSGA-II search in the EI of the GP models (columns) in the initial DoE and 
each optimisation iteration (rows). The Pareto non-dominated solutions along with the 
update points are also mapped onto the design space to ensure exploitation and 
exploration.     
 
Figure 6. Spatial SM superimposed on the deformed stent models after balloon deflation: 
the spatial SM was calculated as the Euclidean distance between triangulated vertex points 
on the external surface of the deformed stent and their normal projections to the deformed 
lumen surface after the virtual stent expansion. 
 
Figure 7. Maximum principal stress plots superimposed on the deformed lumen surface 
after balloon deflation 
 
Figure 8. Final PF obtained by NSGA-II search in the updated surrogates (third iteration 
step): a) the optimum point is selected according to the minimum distance from utopia 
criterion, by applying equal    to the weighted          . b) optimum point selected by 
setting                       .  
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Table 1. Baseline and DoE point parameters and objective function evaluations 
Design  Diameter 
X1 (0 - 1) 
Pressure 
X2 (0 - 1) 
Diameter 
X1 (mm) 
Pressure 
X2 (MPa) 
VAS AASM VAD 
Baseline  0.532 0.268 3.383 0.842 0.0199895 0.0531295 -0.0785628 
DOE_01 0.625  0.525 3.507 1.0725 0.0264650 0.0400620 -0.0859427 
DOE_02 0.474 0.025 3.306  0.622 0.0172700  0.0849213 -0.0672303 
DOE_03 0.275  0.174 3.039 0.757 0.0153593 0.0885886 -0.0630614 
DOE_04 0.174  0.775 2.905 1.297 0.0147054 0.0969262 -0.0610030 
DOE_05 0.325  0.925 3.106 1.432 0.0196714 0.0632130 -0.0757653 
DOE_06 0.925  0.125 3.907 0.712 0.0385187 0.0246679 -0.0927742 
DOE_07 0.074  0.574 2.772 1.117 0.0115248 0.1412866 -0.0463872 
DOE_08 0.974  0.724 3.974 1.252 0.0452974 0.0233686 -0.0926703 
DOE_09 0.025  0.275 2.705 0.847 0.0088470 0.2035017 -0.0310349 
DOE_10 0.125  0.074 2.838 0.667 0.0102840 0.1660097 -0.0377240 
DOE_11 0.824  0.875 3.774 1.387 0.0398379 0.0265523 -0.0912732 
DOE_12 0.724  0.675 3.640 1.207 0.0347925 0.0265455 -0.0914798 
DOE_13 0.525  0.824 3.373 1.342 0.0274498 0.0394250 -0.0873315 
DOE_14 0.574  0.225 3.440 0.802 0.0248069 0.0443346 -0.0833497 
DOE_15 0.375  0.625 3.173 1.162 0.0197208 0.0646653 -0.0746734 
DOE_16 0.775  0.325 3.707 0.892 0.0338754 0.0291174 -0.0906493 
DOE_17 0.424  0.375 3.239 0.937 0.0174558 0.0744635 -0.0690409 
DOE_18 0.875  0.474 3.841 1.027 0.0391969 0.0238637 -0.0924370 
DOE_19 0.225  0.424 2.972 0.982 0.0138717 0.1115204 -0.0552826 
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DOE_20 0.675  0.974 3.573 1.477 0.0325380 0.0308955 -0.0907502 
 
Table 2. Infill point parameters and objective function evaluations 
Design  Diameter 
X1 (0 - 1) 
Pressure 
X2 (0 - 1) 
Diameter 
X1 (mm) 
Pressure 
X2 (MPa) 
VAS AASM VAD 
UPD_01 0 0 2.672  0.6 0.0087020 0.2116110  -0.0291556 
UPD_02 0.935  0.176  3.921  0.758  0.0380468  0.0243901  -0.0923420  
UPD_03 0.715  0 3.627 0.6 0.0276499  0.0394574  -0.0861582 
UPD_11 0.028  0  2.710  0.6 0.0089423  0.2058367  -0.0304440 
UPD_12 0.897  0.767  3.870 1.291  0.0466347  0.0227087 -0.0929400 
UPD_13 0.262  0.761  3.022  1.285  0.0172374  0.0837953 -0.0679390 
UPD_21 0 0.367  2.672  0.931  0.0087822  0.2133572 -0.0294927 
UPD_22 0.901 0.617  3.876 1.156  0.0425773  0.0226643  -0.0920894 
UPD_23 0.651  0.145  3.541  0.731  0.0268951  0.0405922 -0.0851674 
 
 
 
